Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PanAsia Bio President Michael Xu: An Interview With PharmAsia News

This article was originally published in PharmAsia News

Executive Summary

Michael Xu, president of Shanghai-based PanAsia Bio, an emerging R&D-based biotech company, sat down recently with PharmAsia News' China Bureau to discuss the company's technology for drug delivery systems, mainly in PEG-based biomaterials. PEGylation is a process of attaching strands of polyethylene glycol (PEG) to molecules, mostly peptides, proteins and antibody fragments.

You may also be interested in...



Yangtze Delta Expected To Be Largest CRO Cluster By 2015

SUZHOU, China - China's Yangtze delta, which includes Shanghai, Suzhou, Nanjing and Hangzhou, will be the largest CRO cluster in the world by 2015 and Shanghai will be the number one city in the world by number of scientists engaged in commercial drug discovery, Kewen Jin, GM of Charles River China, said during the BioBay Investor Forum in Suzhou Aug. 28

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

ID1131511

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel